醫美板塊再度發力 奧園美谷(000615.SZ)創歷史新高 無懼風險提示
格隆匯5月13日丨醫美板塊異動拉昇,奧園美谷盤中漲超8%,股價最高報27.3元創歷史新高,16個交易日累計漲近140%,現漲幅超6%;

金髮拉比觸及漲停,三友醫療漲超6%,澳洋健康漲超5%,愛美客、復星醫藥、愛博醫療等跟漲。

國金證券表示,國內醫美進入黃金時期,國產企業發展機遇到來:在人均可支配收入增加、大眾對醫美接受程度提高等多重因素推動下,我國醫美市場蓬勃發展, 國內醫美進入黃金時期,國產企業發展機遇到來:未來數年將是醫美行業發展的黃金時期,我們看好醫美行業的整體擴容和滲透率提升趨勢。
值得注意的是,近期大漲的奧園美谷昨日公吿稱,公司目前的主營業務為房地產、化纖新材料和醫美業務,2020年度醫美業務未產生收入。此前澳洋健康公吿稱,公司醫美業務佔公司整體業務規模較小,公司醫美業務受市場、行業標準、技術等因素的影響存在不確定性
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.